COMPANY PROFILE

Sansure Biotech / 圣湘生物

Explore full profile

Molecular diagnostics reagents and instruments (STAR 688289)

Changsha, ChinaFounded 2008Biotech & Life Sciences

Valuation $1–2.5B Last recorded · 2026

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Sansure Biotech / 圣湘生物

Changsha STAR-listed molecular-diagnostics OEM (Sansure Biotech / 圣湘生物; STAR 688289) develops nucleic-acid reagents and instruments plus gene-tech and third-party lab adjacency for infectious-disease and respiratory POCT-adjacent panels. Founded in 2008 and headquartered in Changsha Yuelu Hi-tech Zone, Sansure is a mid-size China molecular IVD manufacturer beyond Mon Hotgen/YHLO and Vazyme coverage.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2008
Headquarters: Changsha, China
Employees: 155
Open positions: None listed
Dealroom signal: 34.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Testing, Biotechnology, Health Diagnostics, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Investment activity: 2 companies, latest Mar 2025
Capital deployed: $84M
Preferred round: SERIES B
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	Jan 2018	$77M	$308M	Lilly Asia Ventures · Highlight Capital	—
FundingOther financing	Aug 2017	$0	—	ShenZhen GTJA Investment Group	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Sansure Biotech / 圣湘生物 website traffic

Latest recorded traffic for Sansure Biotech / 圣湘生物 is 46K monthly website visits, up 3438.5% over the last three months. Sansure Biotech / 圣湘生物's team grew 2% over the past year.

Latest monthly visits46K 3-month web change+3438.5% 1-year team growth+2%

Monthly website visitsFeb 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CDCNA DiagnosticsA molecular diagnostics company developing novel diagnostic tests for a spectrum of complex diseases	Calgary, Canada	Operational	—	$4.3M	—
VIVitroScanDedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients	Leiden, Netherlands	Operational
GEGemmaCertGemmaCert is developing a non-destructive and noninvasive analytical cannabis-testing technology for professional and home use	Ra'anana, Israel	Operational
PGProbably GeneticProbably Genetic helps rare genetic disease patients get diagnosed	San Francisco, United States	Operational
SDSeLux DiagnosticsSeLux Diagnostics is developing universal synthetic amplifier technology equipment for antibiotic susceptibility testing and diagnostics	Boston, United States	Operational
MDMDHcareMDHcare is an in vitro diagnostic reagent and genetic testing service provider	China	Operational
GBGeneCast BiotechnologyIt is a Beijing cancer diagnosis company	Haidian, China	Operational
2323MofangGenetics testing and analyzing Startup Based In China	Chengdu, China	Operational